The FDA Public Hearing On May 31st, 2019 the FDA held a public hearing to discuss the future of CBD products and the industry alike. 120 out of 400 applicants including varying CBD companies, lawyers, doctors, farmers and more pleaded their cases in front of the FDA to help start a conversation about what restrictions
Today, December 20th, 2018, President Trump signed the 2018 Farm Bill, not a new piece of legislature, but an important one for multiple industries. Most important: the hemp industry. For decades, hemp (and CBD oil) have been listed as a Controlled Substance, lumping it alongside marijuana and other intoxicating substances. Moving forward, hemp will be
Updated July 9, 2018 Since its introduction in March, the hemp community has kept a close eye on the movement of the Hemp Farming Act of 2018. If passed, the legislation would explicitly legalize hemp and expand opportunities for hemp businesses. This timeline follows the progression of this legislation. We will continue to make updates as new action takes place. SENATOR
Last week, the Food and Drug Administration (FDA) approved the cannabidiol (CBD) oral solution Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of pediatric epilepsy. “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said FDA Commissioner Scott Gottlieb, M.D. This development has been
In a wellness industry such as CBD, customer service plays a major role. Humans are inquisitive by nature, especially when it comes to health. Even with the proper education on your website, customers are sure to have additional questions. Whether regarding serving size, product recommendations, or order information, we need to be prepared to answer each question thoroughly and to our best knowledge.
After over a year of industry confusion, the Drug Enforcement Agency (DEA) has clarified its stance on cannabis extracts and the Controlled Substances Act (CSA). According to the DEA, cannabis materials or products that do not fall into the definition of marijuana are excluded from the CSA. This means that cannabidiol (CBD) is not a controlled substance if derived from the mature stalk of the
Product content serves as the main form of communication between an online retailer and a potential customer. In the online space, this content replaces the face-to-face conversation. More than just tell the patron what the product is, product content influences purchasing behavior. In the CBD industry, product content plays an important role in education. Customers want to feel confident in the wellness supplement
JENISON, MI, May 9, 2018 – MHR Brands, the parent company to several leading hemp retail and wholesale brands, celebrates five years of business today. Founded by Jeff Gallagher in 2013, MHR Brands manufactures hemp-derived CBD products in the form of concentrates, tinctures, vape oils, edibles, and skin care. What started as an operation out of Gallagher’s basement has flourished into a professional facility and a successful e-commerce platform. MHR Brands is supported by a team of nearly thirty and caters to a global audience.
John Boehner has shifted his stance on marijuana legalization. The former Speaker of the House has joined the advisory board of Acreage Holdings, a cannabis corporation that cultivates, processes and dispenses cannabis in 11 states. “…my thinking on cannabis has evolved,” Boehner said on Twitter. Currently, any variety of cannabis, including hemp, is classified as a schedule I drug by
Updated April 13, 2018. On Monday, March 26, U.S. Senate Majority Leader Mitch McConnell (R-KY) announced he will introduce a bill to legalize hemp. During a speech in Frankfort, Kentucky, McConnell said he would propose the bipartisan bill next week in the Senate. UPDATE: McConnell files the Hemp Farming Act. Titled the Hemp Farming Act of 2018, the proposed bill would legalize hemp as an “agricultural commodity”